mcclick
@kyle
The US gov should pay Novo $175B for the Ozempic patent (~12.5x revenue), hold it defensively, and let co’s manufacture/sell it for cheap. Would have a significant impact on annual cost of obesity ($175B) over the next decade and be a positive ROI for the US. And it’d reward Novo for its research and risk.
6 replies
2 recasts
22 reactions
mcclick
@kyle
Doesn’t involve price controls, allows an open market to enter and drive the price down, incentivizes more pharma R&D, and would improve more than just healthcare costs in the US. Oh and it’d help the rest of the world too.
0 reply
0 recast
0 reaction